Literature DB >> 3024235

PAF antagonists: different effects on platelets, neutrophils, guinea pig ileum and PAF-induced vasodilation in isolated rat lung.

N F Voelkel, S W Chang, K D Pfeffer, S G Worthen, I F McMurtry, P M Henson.   

Abstract

The effects of structurally different PAF receptor blockers were investigated in platelets, neutrophils, guinea pig ileum, rat isolated lung and rat isolated pulmonary artery. PAF caused serotonin release from platelets and a characteristic shape change and adhesion of neutrophils. The antagonists (CV 3988, alprazolam, 48740 RP and Merck-Sharp and Dohme L-652, 731) inhibited platelet serotonin release but not neutrophil shape change adhesion or lysosomal enzyme release. The antagonists in high concentrations (10(-5)-10(-4)M) inhibited nonspecifically the PAF-induced (10(-8)M) guinea pig ileum contraction, but were ineffective at concentrations which inhibited platelet responses. In the rat lung the compounds, in high concentrations, partially inhibited the low dose PAF-induced pulmonary vasodilation and the high dose PAF induced pulmonary vasoconstriction and edema. Our data indicate that some platelet PAF antagonists may be ineffective in blocking the action of PAF on neutrophils and smooth muscle preparations and suggest either PAF-receptor independent actions of PAF or different classes of PAF receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024235     DOI: 10.1016/0090-6980(86)90005-5

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  8 in total

1.  Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta.

Authors:  H Moritoki; T Hisayama; S Takeuchi; H Miyano; W Kondoh
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

2.  Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.

Authors:  J G Filep; M G Sirois; A Rousseau; A Fournier; P Sirois
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

3.  Regulation of the pulmonary circulation in the perinatal period and in children.

Authors:  M A Heymann
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

4.  Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.

Authors:  S W Chang; C O Feddersen; P M Henson; N F Voelkel
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

5.  Metabolism of platelet-activating factor in isolated perfused rat lung.

Authors:  P E Haroldsen; N F Voelkel; J E Henson; P M Henson; R C Murphy
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

6.  Antagonism of Paf-induced oedema formation in rabbit skin: a comparison of different antagonists.

Authors:  P G Hellewell; T J Williams
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

7.  Effects of REV 5901, a 5-lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea-pig.

Authors:  G Anderson; M Fennessy
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

8.  Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.

Authors:  A G Stewart; G J Dusting
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.